Latest Diabetes News
Researchers linked the condition to warfarin use, diabetes, obesity, recurrent skin trauma, and derangements in mineral metabolism.
Between 2002 and 2013, the cost of insulin rose by more than $500 per patient.
Meformin was linked to a 30% to 40% reduced risk of dying from a heart attack or stroke.
Older women with diabetes and cancer taking metformin saw an increase in survival.
Metformin, a widely used oral anti-diabetic drug, enhanced the anti-prostate cancer activity of abiraterone and enzalutamide.
Researchers found no significant differences in instances of CVD in patients treated with GLP-1RA compared to DPP-4i in combination with metformin.
The diabetes drug was contraindicated due to the risk of lactic acidosis.
Researchers suggest that exchanging vegetable protein for animal protein can lower the risk of diabetes.
Evacetrapib did lower low-density lipoprotein cholesterol in high vascular risk patients, but did not reduce major cardiovascular events.
The addition of aliskiren to enalapril led to more adverse events in patients with chronic heart failure without an increase in benefit.
Drugs containing saxagliptin or alogliptin may be linked to heart failure risk.
10-year weight loss intervention tied to lower white matter hyperintensity volume.
Participants assigned to a whey protein lost more weight at 3 months than those assigned to other proteins or starch.
Duration- and dose-response associations for pioglitazone; no correlation for rosiglitazone.
In-trial reduction in risk of ESRD seen in ADVANCE trial persists after 9.9 years of follow-up.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)